SARA SCHAEFER: Open Payments
NPI 1821424334 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,514 in 37 payments from 8 companies in 2025. Trend: 2023 $5,085 · 2024 $18,105 · 2025 $16,514
Consulting: $13,653Food & beverage: $2,120Travel & lodging: $740
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $13,640 |
| Novartis Pharmaceuticals Corporation | 9 | $1,700 |
| TG Therapeutics, Inc. | 6 | $529 |
| EMD Serono, Inc. | 3 | $236 |
| Lilly USA, LLC | 2 | $164 |
| Amgen Inc. | 1 | $130 |
| Biogen, Inc. | 2 | $100 |
| LivaNova USA, Inc. | 1 | $14 |
Products named: KESIMPTA, BRIUMVI, KISUNLA, UPLIZNA, TYSABRI, Mavenclad, VNS THERAPY SENTIVA MODEL 1000 GENERATOR.
Industry payments across CO — which companies pay providers there.
